227 related articles for article (PubMed ID: 16457814)
1. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
Olsen H; Haldosén LA
Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
4. EGF modulates expression of STAT5 in mammary epithelial cells.
Petersen H; Haldosén LA
Exp Cell Res; 1998 Sep; 243(2):347-58. PubMed ID: 9743594
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway.
Kawai M; Namba N; Mushiake S; Etani Y; Nishimura R; Makishima M; Ozono K
J Mol Endocrinol; 2007 Feb; 38(1-2):19-34. PubMed ID: 17242167
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Coyle AT; Kinsella BT
Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
[TBL] [Abstract][Full Text] [Related]
7. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
Tencer L; Burgermeister E; Ebert MP; Liscovitch M
Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
Kim HJ; Woo IS; Kang ES; Eun SY; Kim GH; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Lee HT; Seo HG
Biochem Biophys Res Commun; 2006 Oct; 349(2):660-7. PubMed ID: 16945329
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
Lovekamp-Swan T; Chaffin CL
Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
17. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
[TBL] [Abstract][Full Text] [Related]
19. Specific regulation of rat glial cell line-derived neurotrophic factor gene expression by riluzole in C6 glioma cells.
Caumont AS; Octave JN; Hermans E
J Neurochem; 2006 Apr; 97(1):128-39. PubMed ID: 16524382
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor functional activity changes during differentiation of mammary epithelial cells.
Faulds MH; Olsen H; Helguero LA; Gustafsson JA; Haldosén LA
Mol Endocrinol; 2004 Feb; 18(2):412-21. PubMed ID: 14605098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]